Peter Kruger is Deputy Director of Intensive Care at the Princess Alexandra Hospital in Brisbane and an Associate Professor at both the University of Queensland and Monash University, Melbourne.
He holds specialist qualifications in both Anaesthesia and Intensive Care and has considerable experience in both laboratory and clinical research. He was the lead investigator of the CTG endorsed NHMRC funded STATInS Trial, looking at Atorvastatin as an adjuvant for the treatment of severe sepsis. In addition to his clinical and teaching roles his active research interests include clinical trial design, weaning patients from mechanical ventilation and the management of severe sepsis.
He is the immediate past chair and a senior examiner for the first part examination of the College of Intensive care medicine of Australia and New Zealand and a primary examiner in pharmacology for the Australian and New Zealand College of Anaesthetists. He has previously been a member of the ANZICS Clinical trials group Executive and is currently a director of the board of the ANZICS Intensive Care Foundation and has recently been elected to the board of the College of Intensive Care Medicine of Australia and New Zealand.